Dutch Health Profile and Purchasing Power
The following chart shows the massive potential in the Dutch pharmaceuticals and healthcare markets; a population of almost 17 million with high per…
Tagged with Holland
The Netherlands: A Fertile Garden for Innovation
Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by Schering Plough, the Netherlands…
Dutch Healthcare: “Innovation with Collaboration”
In keeping with its reputation as a forerunner, the Dutch healthcare eco-system is currently reinventing itself to ensure it remains ahead of the game…
Forging the Future of Healthcare in the Netherlands
The Netherlands is clearly a fertile environment for its 2,200 life science and medtech companies. However, the Dutch ambition to be a frontrunner in…
Interview: Karel Fol – Country Manager Benelux, Sobi, The…
Sobi is a leading integrated biopharmaceutical company dedicated to developing innovative therapies and services to improve the lives of rare disease…
Interview: Hans Hofstraat – Vice President, Philips…
In an exclusive interview, the Vice President of Philips Research explains the key to continuous evolution, improving healthcare stakeholder…
Interview: Roland van Esch – Managing Director, Zimmer…
Healthcare is moving towards an increased level of personalization and active participation of the patient in the decision-making process. Roland van…
Interview: Hennie Henrichs – General Manager Benelux &…
Teva Benelux and Nordics’ GM lifts the lid on how the company has grown to become the market leader in the Netherlands. Looking at Teva’s…
Interview: Yvonne van Rooy – President, NVZ, The…
Yvonne van Rooy, president of the NVZ, explains the patient’s increasing role as a partner in Dutch healthcare and how greater investment in…
Interview: Bart Coenen – Senior VP Contract Logistics;…
DB Schenker’s Bart Coenen (BC) and Vincent Coolen (VC) explain the company’s Vision 2020 and talk about the benefits for pharma companies…
Interview: Roeland Van Dam – CEO, Bilthoven Biologicals,…
Roeland Van Dam, CEO of Bilthoven Biologicals, a historical Dutch company which remains at the forefront of vaccine production, explains how being…
Interview: Han Brouwer – General Manager, Actelion…
Han Brouwer, General Manager for Actelion in the Netherlands, explains how Opsumit’s successful market launch has strengthened Actelion’s…
